elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34113564-2CA1FEA2-0BFA-4296-A64A-F1FBADEDE41D
Q34113564-2CA1FEA2-0BFA-4296-A64A-F1FBADEDE41D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34113564-2CA1FEA2-0BFA-4296-A64A-F1FBADEDE41D
Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian cancer: further analysis of a prospective study
P2860
Q34113564-2CA1FEA2-0BFA-4296-A64A-F1FBADEDE41D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34113564-2CA1FEA2-0BFA-4296-A64A-F1FBADEDE41D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea484ad3a47e86c6c6a3d2b8c9cf723633b15059
P2860
American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.